Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Manhattan Scientifics Inc. (MHTX : OTC)

• Company Description    Manhattan Scientifics Inc. is a technology solutions provider that focuses on the nanomedicine space. The Company acts as a technology incubator that acquires, develops and commercializes life-enhancing technologies in various fields, with emphasis in the areas of alternative energy, and consumer and commercial electronics. Manhattan has three wholly owned subsidiaries of which Metallicum is the only operating subsidiary; and Tamarack and Teneo are dormant. Metallicum is a nanotechnology start-up company that focuses on the development and manufacture of nanostructured metals for medical implants and other applications. Metallicum's initial products include nanostructured bulk metals and alloys in the form of rod, bar, wire and foil. Manhattan Scientifics Inc. conducts its operations primarily in the United States and has its offices in New Mexico, New York and Montreal. Number of Employees: 3

• Price / Volume Information    Yesterday's Closing Price: $0.00 Daily Weekly Monthly 20 Day Moving Average: 126,110 shares Shares Outstanding: 559.28 (millions) Market Capitalization: $0.06 (millions) Beta: 1.33 52 Week High: $0.00 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% -4.34% 12 Week 0.00% -18.42% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 244 Fifth Ave Suite 2341 - New York,NY 10001 USA ph: 212-541-2405 fax: - marvin@mhtx.com http://www.mhtx.com

• General Corporate Information    Officers Emmanuel Tsoupanarias - Chief Executive Officer;President and Director Marvin Maslow - Chairman of the Board Frank Georgiou - Director Frank Georgiou - Director Larry Schatz - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Nanotechnology Sector: Computer and Technology CUSIP: 563122100 SIC: 3690 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/24 Next Expected EPS Date: 08/18/25 Share - Related Items Shares Outstanding: 559.28 Most Recent Split Date: (:1) Beta: 1.33 Market Capitalization: $0.06 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/18/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©